156 related articles for article (PubMed ID: 37916989)
1. Identification and diagnostic potential of serum microRNAs as biomarkers for early detection of Alzheimer's disease.
Han YH; Xiang HY; Lee DH; Feng L; Sun HN; Jin MH; Kwon T
Aging (Albany NY); 2023 Nov; 15(21):12085-12103. PubMed ID: 37916989
[TBL] [Abstract][Full Text] [Related]
2. Identification and validation of endogenous control miRNAs in plasma samples for normalization of qPCR data for Alzheimer's disease.
Dakterzada F; Targa A; Benítez ID; Romero-ElKhayat L; de Gonzalo-Calvo D; Torres G; Moncusí-Moix A; Huerto R; Sánchez-de-la-Torre M; Barbé F; Piñol-Ripoll G
Alzheimers Res Ther; 2020 Dec; 12(1):163. PubMed ID: 33278902
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA Expression Signature in Mild Cognitive Impairment Due to Alzheimer's Disease.
De Felice B; Montanino C; Oliva M; Bonavita S; Di Onofrio V; Coppola C
Mol Neurobiol; 2020 Nov; 57(11):4408-4416. PubMed ID: 32737762
[TBL] [Abstract][Full Text] [Related]
4. Profile of Pathogenic Proteins and MicroRNAs in Plasma-derived Extracellular Vesicles in Alzheimer's Disease: A Pilot Study.
Li F; Xie XY; Sui XF; Wang P; Chen Z; Zhang JB
Neuroscience; 2020 Apr; 432():240-246. PubMed ID: 32135232
[TBL] [Abstract][Full Text] [Related]
5. Can Peripheral MicroRNA Expression Data Serve as Epigenomic (Upstream) Biomarkers of Alzheimer's Disease?
Yılmaz ŞG; Erdal ME; Özge AA; Sungur MA
OMICS; 2016 Aug; 20(8):456-61. PubMed ID: 27501295
[TBL] [Abstract][Full Text] [Related]
6. A 9-microRNA Signature in Serum Serves as a Noninvasive Biomarker in Early Diagnosis of Alzheimer's Disease.
Guo R; Fan G; Zhang J; Wu C; Du Y; Ye H; Li Z; Wang L; Zhang Z; Zhang L; Zhao Y; Lu Z
J Alzheimers Dis; 2017; 60(4):1365-1377. PubMed ID: 29036818
[TBL] [Abstract][Full Text] [Related]
7. Serum microRNA miR-501-3p as a potential biomarker related to the progression of Alzheimer's disease.
Hara N; Kikuchi M; Miyashita A; Hatsuta H; Saito Y; Kasuga K; Murayama S; Ikeuchi T; Kuwano R
Acta Neuropathol Commun; 2017 Jan; 5(1):10. PubMed ID: 28137310
[TBL] [Abstract][Full Text] [Related]
8. Serum microRNA array analysis identifies miR-140-3p, miR-33b-3p and miR-671-3p as potential osteoarthritis biomarkers involved in metabolic processes.
Ntoumou E; Tzetis M; Braoudaki M; Lambrou G; Poulou M; Malizos K; Stefanou N; Anastasopoulou L; Tsezou A
Clin Epigenetics; 2017; 9():127. PubMed ID: 29255496
[TBL] [Abstract][Full Text] [Related]
9. Type 2 Diabetes Mellitus and its comorbidity, Alzheimer's disease: Identifying critical microRNA using machine learning.
Alamro H; Bajic V; Macvanin MT; Isenovic ER; Gojobori T; Essack M; Gao X
Front Endocrinol (Lausanne); 2022; 13():1084656. PubMed ID: 36743910
[TBL] [Abstract][Full Text] [Related]
10. Lower Serum Levels of miR-29c-3p and miR-19b-3p as Biomarkers for Alzheimer's Disease.
Wu Y; Xu J; Xu J; Cheng J; Jiao D; Zhou C; Dai Y; Chen Q
Tohoku J Exp Med; 2017 Jun; 242(2):129-136. PubMed ID: 28626163
[TBL] [Abstract][Full Text] [Related]
11. Usefulness of candidate mRNAs and miRNAs as biomarkers for mild cognitive impairment and Alzheimer's disease.
Qin H; Hu C; Zhao X; Tian M; Zhu B
Int J Neurosci; 2023 Jan; 133(1):89-102. PubMed ID: 33541173
[TBL] [Abstract][Full Text] [Related]
12. A Systematic Review of MicroRNA Expression as Biomarker of Late-Onset Alzheimer's Disease.
Herrera-Espejo S; Santos-Zorrozua B; Álvarez-González P; Lopez-Lopez E; Garcia-Orad Á
Mol Neurobiol; 2019 Dec; 56(12):8376-8391. PubMed ID: 31240600
[TBL] [Abstract][Full Text] [Related]
13. Serum Exosomal miRNA-125b and miRNA-451a are Potential Diagnostic Biomarker for Alzheimer's Diseases.
Duan X; Zheng Q; Liang L; Zhou L
Degener Neurol Neuromuscul Dis; 2024; 14():21-31. PubMed ID: 38618193
[TBL] [Abstract][Full Text] [Related]
14. Plasma miR-34a-5p and miR-545-3p as Early Biomarkers of Alzheimer's Disease: Potential and Limitations.
Cosín-Tomás M; Antonell A; Lladó A; Alcolea D; Fortea J; Ezquerra M; Lleó A; Martí MJ; Pallàs M; Sanchez-Valle R; Molinuevo JL; Sanfeliu C; Kaliman P
Mol Neurobiol; 2017 Sep; 54(7):5550-5562. PubMed ID: 27631879
[TBL] [Abstract][Full Text] [Related]
15. A New Discovery of MicroRNA-455-3p in Alzheimer's Disease.
Kumar S; Reddy PH
J Alzheimers Dis; 2019; 72(s1):S117-S130. PubMed ID: 31524168
[TBL] [Abstract][Full Text] [Related]
16. Exploiting machine learning models to identify novel Alzheimer's disease biomarkers and potential targets.
Alamro H; Thafar MA; Albaradei S; Gojobori T; Essack M; Gao X
Sci Rep; 2023 Mar; 13(1):4979. PubMed ID: 36973386
[TBL] [Abstract][Full Text] [Related]
17. MiRNA -483-5p as a Potential Noninvasive Biomarker for Early Detection of Alzheimer's Disease.
Sabry R; El Sharkawy RE; Gad NM
Egypt J Immunol; 2020 Jun; 27(2):59-72. PubMed ID: 33548978
[TBL] [Abstract][Full Text] [Related]
18. Inflammation-Related microRNAs-146a and -155 Are Upregulated in Mild Cognitive Impairment Subjects Among Older Age Population in Montenegro.
Rovčanin Dragović I; Popović N; Ždralević M; Radulović L; Vuković T; Marzano F; Tullo A; Radunović M
J Alzheimers Dis; 2022; 90(2):625-638. PubMed ID: 36155522
[TBL] [Abstract][Full Text] [Related]
19. Serum MicroRNA Profiles Serve as Novel Biomarkers for the Diagnosis of Alzheimer's Disease.
Dong H; Li J; Huang L; Chen X; Li D; Wang T; Hu C; Xu J; Zhang C; Zen K; Xiao S; Yan Q; Wang C; Zhang CY
Dis Markers; 2015; 2015():625659. PubMed ID: 26078483
[TBL] [Abstract][Full Text] [Related]
20. Combinatory microRNA serum signatures as classifiers of Parkinson's disease.
Patil KS; Basak I; Dalen I; Hoedt E; Lange J; Lunde KA; Liu Y; Tysnes OB; Forsgren L; Aarsland D; Neubert TA; Larsen JP; Alves G; Møller SG
Parkinsonism Relat Disord; 2019 Jul; 64():202-210. PubMed ID: 31003905
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
